719 Results for "

MG degrader1

" in MedChemExpress (MCE) Product Catalog:
Products (719)

719 Results for "MG degrader1" in MCE Product Catalog:

162
162 Publications Verification
Cat. No.: HY-13982
CAS No.: 749886-87-1
Purity:  99.30%
Target:  

NF-κB

JSH-23 is an NF-κB inhibitor which inhibits NF-κB transcriptional activity with an IC50 of 7.1 μM in lipopolysaccharide (LPS)-stimulated macrophages RAW 264.7. JSH-23 inhibits nuclear translocation of NF-κB p65 without affecting IκBα degradation .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-119932
CAS No.: 2301916-69-6
Purity:  99.25%
Target:  

PROTACs FAK Akt

Research Areas:  

Cancer

PROTAC FAK degrader 1 (Compound PROTAC-3) is a selective and effective degrader of Fak PROTAC with a DC50 of 3.0 nM. PROTAC FAK degrader 1 reduces the ability of cancer cells to migrate and invade. PROTAC FAK degrader 1 can be used in the study of tumor .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-W017389
CAS No.: 69-89-6
Xanthine, a plant alkaloid found in tea, coffee, and cocoa, is a mild stimulant of the central nervous system. Xanthine also acts as an intermediate product on the pathway of purine degradation .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-125878
CAS No.: 2381320-35-8
Purity:  99.89%
Synonyms: SGK3-PROTAC1
Target:  

PROTACs SGK

Research Areas:  

Cancer

PROTAC SGK3 degrader-1 (SGK3-PROTAC1), a chemical probe, is a von Hippel-Lindau ligand-based SKG3 PROTAC composed of a PEG3-C4-OBn (HY-130620) alkyl linker, an SGK3 degrader (red structure), and a VHL ligand (HY-150803, blue structure). PROTAC SGK3 degrader-1 (0.3 μM) induced 50% endogenous SGK3 degradation within 2 hours, and 80% SGK3 degradation was observed at 8 hours, accompanied by loss of phosphorylation of NDRG1 (SGK3 substrate) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-N6769
CAS No.: 12772-57-5
Synonyms: Monorden
Radicicol is an inhibitor of Hsp90 with an IC50 value < 1 μM, and leads to proteasomal degradation . Radicicol exhibits inhibition on PDK with IC50s of 230 μM (PDK1) and 400 μM (PDK3). Radicicol is an antifungal and antimalarial antibiotic, impairs mitochondrial replication by targeting P. falciparum topoisomerase VIB . Radicicol is also an inhibitor of fat mass and obesity-associated protein (FTO), with an IC50 value of 16.04 μM .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-103632
CAS No.: 2097971-01-0
Purity:  99.16%
Research Areas:  

Cancer

PROTAC BRD9 Degrader-1 is a PROTAC connected by ligands for Cereblon and BRD9 (IC50=13.5 nM), which can be used as a selective probe useful for the study of BAF complex biology .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-113136
CAS No.: 2140-65-0
Purity:  98.39%
Synonyms: N1-Methylguanosine
1-Methylguanosine (N1-Methylguanosine) is a methylated nucleoside originating from RNA degradation. 1-Methylguanosine is a tumour marker .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-126534
CAS No.: 2704316-81-2
Purity:  98.01%
Synonyms: LSN3106729
Research Areas:  

Cancer

Abemaciclib metabolite M18 (LSN3106729), the metabolite of Abemaciclib (HY-16297A), is a CDK inhibitor with antitumor activity. Abemaciclib metabolite M18 and a CRBN ligand have been used to design PROTAC CDK4/6 degrader .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-126534A
CAS No.: 2704316-82-3
Purity:  98.18%
Synonyms: LSN3106729 hydrochloride
Research Areas:  

Cancer

Abemaciclib metabolite M18 (LSN3106729) hydrochloride, the metabolite of Abemaciclib (HY-16297A), is a CDK inhibitor with antitumor activity. Abemaciclib metabolite M18 hydrochloride and a CRBN ligand have been used to design PROTAC CDK4/6 degrader .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-145479
CAS No.: 2767440-24-2
Purity:  98.19%
Research Areas:  

Cancer

PROTAC AR-V7 degrader-1 is a selective AR-V7 degrader with a DC50 of 0.32 μM. PROTAC AR-V7 degrader-1 inhibits cancer cell proliferation. PROTAC AR-V7 degrader-1 is applicable to the research of castration-resistant prostate cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-103633
CAS No.: 2093386-22-0
Purity:  99.41%
Research Areas:  

Cancer

PROTAC BET Degrader-1 is a BRD2/BRD3/BRD4 PROTAC degrader. PROTAC BET Degrader-1 inhibits the growth of acute leukemia cells. PROTAC BET Degrader-1 is applicable to the research of acute leukemia .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-138536
CAS No.: 2484739-48-0
Purity:  98.30%
PROTAC CBP/P300 Degrader-1 is a potent PROTAC CBP/P300 degrader. PROTAC CBP/P300 Degrader-1 potently inhibited cell viability of multiple cancer cell lines .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-129523
CAS No.: 2378258-52-5
Purity:  95.66%
Target:  

PROTACs Ras

Research Areas:  

Cancer

PROTAC K-Ras Degrader-1 is a K-Ras PROTAC degrader. It binds to both K-Ras and the Cereblon E3 ubiquitin ligase, bringing K-Ras into proximity with the ligase, thereby achieving its degradation and inhibition. PROTAC K-Ras Degrader-1 can be used for research in various cancers .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-103628
CAS No.: 2118356-96-8
Purity:  99.55%
Target:  

PROTACs CDK

Research Areas:  

Cancer

PROTAC CDK9 Degrader-1 is a PROTAC connected by ligands for Cereblon and CDK as a selective CDK9 degrader.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-155008
CAS No.: 3033812-84-6
Purity:  98.98%
Target:  

PROTACs Hexokinase

Research Areas:  

Cancer

PROTAC HK2 Degrader-1 is a PROTAC consisting of Lonidamine (HY-B0486) as a target protein Hexokinase 2 (HK2) inhibitor and Thalidomide (HY-14658) as a CRBN ligand-linked PROTAC. PROTAC HK2 Degrader-1 selectively inhibits the proliferation of breast cancer cells by forming a ternary complex through the ubiquitin-proteasome system to degrade Hexokinase 2 (HK2) protein leading to mitochondrial damage and cell death. PROTAC HK2 Degrader-1 effectively inhibits breast tumor growth and reduces the colonic side effects of cisplatin for breast cancer research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-120722
CAS No.: 1446350-60-2
Purity:  98.42%
Target:  

Proteasome

Research Areas:  

Cancer

TCH-165 is a small molecule modulator of proteasome assembly, which increases 20S levels and facilitates 20S-mediated protein degradation .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-131295
CAS No.: 2581116-22-3
Purity:  98.62%
Research Areas:  

Cancer

PD0325901-O-C2-dioxolane has main portion of MEK inhibitor PD0325901. PD0325901-O-C2-dioxolane and a ligand of VHL or CRBN E3 ligase can be used in the synthesis of MEK1/2 degrader .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-141894
CAS No.: 2990123-10-7
Purity:  99.04%
Research Areas:  

Metabolic Disease

5-Ph-IAA-AM is an eggshell-permeable 5-Ph-IAA (HY-134653) analog which contains an acetoxymethyl (AM) group. 5-Ph-IAA-AM affords an enhanced protein degradation in laid embryos. 5-Ph-IAA-AM can be used to disclosure the roles of proteins in C. elegans, in particular those that are involved in embryogenesis and development, through temporally controlled protein degradation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-150608
CAS No.: 2762552-74-7
Purity:  98.26%
Target:  

PROTACs STING

Research Areas:  

Inflammation/Immunology Cancer

PROTAC STING Degrader-1 is a PROTAC degrader targeting the STING pathway with a DC50 of 3.2 μM. PROTAC STING Degrader-1 exerts high anti-inflammatory efficacy. PROTAC STING Degrader-1 can be used to study diseases such as acute kidney injury and inflammatory bowel diseases (IBDs) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-163638
CAS No.: 3094209-54-5
BRD4 degrader-1 (Compound mL 1-50) is a relatively selective, monovalent and covalent BRD4 Molecular glue degrader. BRD4 degrader-1 induces degradation of both long and short isoforms of BRD4 by targeting DCAF16 (an E3 ligase). BRD4 degrader-1 can be used in breast cancer research .
loading...
    loading...